Clements Ian
SEC CIK 1780080 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | CFO | 30.0K | $20.5K | $30.3K | 7 | 2021-09-29 | 2022-11-10 |
Most active insiders at MIRM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Peetz Christopher | CEO, Dir | — | $16.29M |
| 2 | GREY MICHAEL G | Dir | — | $11.10M |
| 3 | Heron Patrick J | Dir | $9.00M | — |
| 4 | Howe Jolanda | SVP, Gbl Ctrl | — | $5.55M |
| 5 | BJERKHOLT ERIC | CFO | — | $3.56M |
| 6 | Radovich Peter | Pres AND COO | — | $2.32M |
| 7 | Ramasastry Saira | Dir | — | $1.92M |
| 8 | Quan Joanne | Chief MEDICAL Off | — | $1.46M |
| 9 | Cardon Lon | Dir | — | — |
| 10 | Fischer Laurent | Dir | — | — |
Clements Ian made no open-market trades at MIRM in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-14 | 2022-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | A - Grant | $17.05 | +325 | 30.0K | +1% | +$5,541 | |
| 2022-05-12 | 2022-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | A - Grant | $13.57 | +1,125 | 29.7K | +4% | +$15.3K | |
| D | 2022-01-07 | 2022-01-06 | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | A - Grant | $0.00 | +10.0K | 28.6K | +54% | $0 |
| M | 2021-11-29 | 2021-11-24+ | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | P - Purchase | $14.14 | +1,450 | 18.6K | +8% | +$20.5K |
| 2021-11-15 | 2021-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | A - Grant | $13.52 | +458 | 17.1K | +3% | +$6,192 | |
| 2021-10-01 | 2021-09-29 | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | A - Grant | $0.00 | +9,375 | 18.2K | +106% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Mirum Pharmaceuticals, Inc. | Clements Ian | CFO | S - Sale | $19.26 | -1,574 | 16.7K | -9% | -$30.3K |
Purchase Sale Sale after option exercise All abbreviations